Thermo–Qaigen Merger Stopped, More IVDs Report Q2 Earnings

EACH TIME A MAJOR IN VITRO DIAGNOSTICS (IVD) COMPANY reports its quarterly earnings, clinical lab executives and pathologists gain useful new perspectives as to how the COVID-19 pandemic is fueling demand for IVD instruments, tests, and lab consumables. In this round-up of the most recent quarterly earnings reports, we provide details about Thermo Fisher Scientific, Agilent Technologies, bioMerieux, Bio-Rad, and Sysmex Corporation. IVD …

Thermo–Qaigen Merger Stopped, More IVDs Report Q2 Earnings Read More »

To access this post, you must purchase The Dark Report.

Thermo–Qaigen Merger Stopped, More IVDs Report Q2 Earnings

Quarterly earnings statements confirm ongoing and strong demand for COVID-19 supplies, tests

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month